Mirum Pharmaceuticals, Inc. (MIRM) Net margin 2021–2025
Mirum Pharmaceuticals, Inc. (MIRM) net profit margin by fiscal year — reported net income divided by reported revenue.
-4.5%FY2025 · since FY2021: -438.9% → -4.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -4.5% | +21.6 pp |
| FY2024 | -26.1% | +61.6 pp |
| FY2023 | -87.7% | +88.4 pp |
| FY2022 | -176.0% | +262.8 pp |
| FY2021 | -438.9% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More MIRM financial trends
MIRM RevenueMIRM Net incomeMIRM Gross profitMIRM Gross marginMIRM Operating incomeMIRM Operating marginMIRM Operating cash flowMIRM Free cash flowMIRM Capital expendituresMIRM Return on equityMIRM Stock buybacksMIRM Dividends paidMIRM Total assetsMIRM Total liabilitiesMIRM Shareholders’ equityMIRM overview →